Symbols / TMO $513.98 -2.02% Thermo Fisher Scientific Inc.

Healthcare • Diagnostics & Research • United States • NYQ
TMO Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Fundamentals
Scroll to Statements
Market Cap 191.01B Enterprise Value 226.25B Income 6.70B Sales 44.56B Book/sh 141.96 Cash/sh 27.20
Dividend Yield 34.00% Payout 9.70% Employees 125000 IPO — P/E 28.99 Forward P/E 18.94
PEG 1.95 P/S 4.29 P/B 3.62 P/C — EV/EBITDA 20.31 EV/Sales 5.08
Quick Ratio 1.36 Current Ratio 1.89 Debt/Eq 77.25 LT Debt/Eq — EPS (ttm) 17.73 EPS next Y 27.14
EPS Growth 9.30% Revenue Growth 7.20% Earnings 2026-04-23 ROA 5.03% ROE 13.02% ROIC —
Gross Margin 41.08% Oper. Margin 21.17% Profit Margin 15.05% Shs Outstand 371.62M Shs Float 370.55M Short Float 1.10%
Short Ratio 1.90 Short Interest — 52W High 643.99 52W Low 385.46 Beta 0.97 Avg Volume 2.18M
Volume 1.80M Target Price $647.38 Recom Strong_buy Prev Close $524.57 Price $513.98 Change -2.02%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$647.38
Mean price target
2. Current target
$513.98
Latest analyst target
3. DCF / Fair value
$212.68
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$513.98
Low
$520.00
High
$750.00
Mean
$647.38

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-14 main Barclays Overweight → Overweight $625
2026-04-06 main Evercore ISI Group Outperform → Outperform $575
2026-01-30 main Citigroup Buy → Buy $685
2026-01-30 main TD Cowen Buy → Buy $683
2026-01-30 main Barclays Overweight → Overweight $650
2026-01-09 main Stifel Buy → Buy $700
2026-01-07 main TD Cowen Buy → Buy $696
2025-12-15 main Wells Fargo Overweight → Overweight $675
2025-12-11 up Citigroup Neutral → Buy $660
2025-12-09 init Goldman Sachs — → Buy $685
2025-12-08 up Keybanc Sector Weight → Overweight $750
2025-12-02 main Morgan Stanley Overweight → Overweight $670
2025-12-01 up HSBC Hold → Buy $670
2025-10-29 main Argus Research Buy → Buy $610
2025-10-28 main Morgan Stanley Overweight → Overweight $656
2025-10-23 main UBS Neutral → Neutral $590
2025-10-23 main TD Cowen Buy → Buy $654
2025-10-23 main Wells Fargo Overweight → Overweight $635
2025-10-23 main Barclays Overweight → Overweight $625
2025-10-23 main Citigroup Neutral → Neutral $580
News
RSS: Latest TMO news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-11 SHAFER MICHAEL D Officer — 1,607 $499.40 $802,536
2026-03-05 CASPER MARC N Chief Executive Officer — 4,000 $503.66 $2,059,261
2026-03-05 CASPER MARC N Chief Executive Officer — 4,000 $309.63 $1,238,520
2026-03-04 CASPER MARC N Chief Executive Officer — 10,000 $495.29 $5,077,489
2026-03-04 CASPER MARC N Chief Executive Officer — 10,000 $309.63 $3,096,300
2026-02-25 PETTITI GIANLUCA Officer — 5,772 $0.00 $0
2026-02-25 HOLMES JOSEPH R. Officer — 770 $0.00 $0
2026-02-25 SHAFER MICHAEL D Officer — 4,698 $0.00 $0
2026-02-25 SHROPSHIRE THOMAS B JR. General Counsel — 978 $0.00 $0
2026-02-25 LAGARDE MICHEL Chief Operating Officer — 2,231 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
44,557.00
+3.91%
42,879.00
+0.05%
42,857.00
-4.58%
44,915.00
Operating Revenue
44,557.00
+3.91%
42,879.00
+0.05%
42,857.00
-4.58%
44,915.00
Cost Of Revenue
26,318.00
+4.53%
25,177.00
-2.25%
25,757.00
-0.72%
25,944.00
Reconciled Cost Of Revenue
26,318.00
+4.53%
25,177.00
-2.25%
25,757.00
-0.72%
25,944.00
Gross Profit
18,239.00
+3.03%
17,702.00
+3.52%
17,100.00
-9.86%
18,971.00
Operating Expense
10,129.00
+1.44%
9,985.00
+2.08%
9,782.00
-6.52%
10,464.00
Research And Development
1,397.00
+0.50%
1,390.00
+3.96%
1,337.00
-9.11%
1,471.00
Selling General And Administration
8,732.00
+1.59%
8,595.00
+1.78%
8,445.00
-6.09%
8,993.00
Total Expenses
36,447.00
+3.65%
35,162.00
-1.06%
35,539.00
-2.39%
36,408.00
Operating Income
8,110.00
+5.09%
7,717.00
+5.45%
7,318.00
-13.98%
8,507.00
Total Operating Income As Reported
7,746.00
+5.57%
7,337.00
+6.97%
6,859.00
-18.28%
8,393.00
EBITDA
11,507.00
-0.24%
11,535.00
+4.12%
11,079.00
-7.23%
11,942.00
Normalized EBITDA
11,856.00
-0.31%
11,893.00
+2.67%
11,584.00
-5.18%
12,217.00
Reconciled Depreciation
2,780.00
-10.55%
3,108.00
-8.75%
3,406.00
+0.74%
3,381.00
EBIT
8,727.00
+3.56%
8,427.00
+9.83%
7,673.00
-10.37%
8,561.00
Total Unusual Items
-349.00
+2.51%
-358.00
+29.11%
-505.00
-83.64%
-275.00
Total Unusual Items Excluding Goodwill
-349.00
+2.51%
-358.00
+29.11%
-505.00
-83.64%
-275.00
Special Income Charges
-362.00
+4.49%
-379.00
+17.43%
-459.00
-302.63%
-114.00
Restructuring And Mergern Acquisition
362.00
-4.49%
379.00
-17.43%
459.00
+302.63%
114.00
Net Income
6,704.00
+5.82%
6,335.00
+5.67%
5,995.00
-13.74%
6,950.00
Pretax Income
7,308.00
+3.85%
7,037.00
+11.73%
6,298.00
-19.62%
7,835.00
Net Non Operating Interest Income Expense
-426.00
-36.54%
-312.00
+37.10%
-496.00
-9.25%
-454.00
Interest Expense Non Operating
1,419.00
+2.09%
1,390.00
+1.09%
1,375.00
+89.39%
726.00
Net Interest Income
-426.00
-36.54%
-312.00
+37.10%
-496.00
-9.25%
-454.00
Interest Expense
1,419.00
+2.09%
1,390.00
+1.09%
1,375.00
+89.39%
726.00
Interest Income Non Operating
993.00
-7.88%
1,078.00
+22.64%
879.00
+223.16%
272.00
Interest Income
993.00
-7.88%
1,078.00
+22.64%
879.00
+223.16%
272.00
Other Income Expense
-374.00
-1.91%
-367.00
+29.96%
-524.00
-140.37%
-218.00
Other Non Operating Income Expenses
-25.00
-177.78%
-9.00
+52.63%
-19.00
-133.33%
57.00
Gain On Sale Of Security
13.00
-38.10%
21.00
+145.65%
-46.00
+71.43%
-161.00
Tax Provision
547.00
-16.74%
657.00
+131.34%
284.00
-59.60%
703.00
Tax Rate For Calcs
0.00
-19.35%
0.00
+106.24%
0.00
-49.90%
0.00
Tax Effect Of Unusual Items
-26.18
+21.38%
-33.29
-46.20%
-22.77
+7.99%
-24.75
Net Income Including Noncontrolling Interests
6,721.00
+6.04%
6,338.00
+6.43%
5,955.00
-14.44%
6,960.00
Net Income From Continuing Operation Net Minority Interest
6,704.00
+5.82%
6,335.00
+5.67%
5,995.00
-13.74%
6,950.00
Net Income From Continuing And Discontinued Operation
6,704.00
+5.82%
6,335.00
+5.67%
5,995.00
-13.74%
6,950.00
Net Income Continuous Operations
6,721.00
+6.04%
6,338.00
+6.43%
5,955.00
-14.44%
6,960.00
Minority Interests
-17.00
-466.67%
-3.00
-107.50%
40.00
+500.00%
-10.00
Normalized Income
7,026.82
+5.51%
6,659.71
+2.82%
6,477.23
-10.04%
7,200.25
Net Income Common Stockholders
6,704.00
+5.82%
6,335.00
+5.67%
5,995.00
-13.74%
6,950.00
Diluted EPS
17.74
+7.32%
16.53
+6.99%
15.45
-12.37%
17.63
Basic EPS
17.77
+7.18%
16.58
+6.83%
15.52
-12.56%
17.75
Basic Average Shares
377.00
-1.31%
382.00
-1.04%
386.00
-1.53%
392.00
Diluted Average Shares
378.00
-1.31%
383.00
-1.29%
388.00
-1.52%
394.00
Diluted NI Availto Com Stockholders
6,704.00
+5.82%
6,335.00
+5.67%
5,995.00
-13.74%
6,950.00
Earnings From Equity Interest Net Of Tax
-41.00
+2.38%
-42.00
+28.81%
-59.00
+65.70%
-172.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
110,343.00
+13.38%
97,321.00
-1.42%
98,726.00
+1.62%
97,154.00
Current Assets
28,707.00
+29.68%
22,137.00
-9.97%
24,589.00
-2.54%
25,229.00
Cash Cash Equivalents And Short Term Investments
10,105.00
+81.42%
5,570.00
-31.06%
8,080.00
-5.21%
8,524.00
Cash And Cash Equivalents
9,852.00
+145.75%
4,009.00
-50.37%
8,077.00
-5.24%
8,524.00
Other Short Term Investments
253.00
-83.79%
1,561.00
+51933.33%
3.00
—
Receivables
10,566.00
+9.77%
9,626.00
-0.39%
9,664.00
+2.51%
9,427.00
Accounts Receivable
8,900.00
+8.66%
8,191.00
-0.36%
8,221.00
+1.31%
8,115.00
Gross Accounts Receivable
9,047.00
+8.17%
8,364.00
-0.59%
8,414.00
+1.32%
8,304.00
Allowance For Doubtful Accounts Receivable
-147.00
+15.03%
-173.00
+10.36%
-193.00
-2.12%
-189.00
Other Receivables
1,666.00
+16.10%
1,435.00
-0.55%
1,443.00
+9.98%
1,312.00
Inventory
5,425.00
+8.98%
4,978.00
-2.16%
5,088.00
-9.69%
5,634.00
Raw Materials
1,877.00
+4.10%
1,803.00
-12.35%
2,057.00
-14.47%
2,405.00
Work In Process
889.00
+17.75%
755.00
+7.09%
705.00
+6.82%
660.00
Finished Goods
2,659.00
+9.88%
2,420.00
+4.04%
2,326.00
-9.46%
2,569.00
Restricted Cash
—
—
—
12.00
Other Current Assets
2,611.00
+33.01%
1,963.00
+11.72%
1,757.00
+6.87%
1,644.00
Total Non Current Assets
81,636.00
+8.58%
75,184.00
+1.41%
74,137.00
+3.08%
71,925.00
Net PPE
10,565.00
+13.53%
9,306.00
-1.50%
9,448.00
+1.81%
9,280.00
Gross PPE
18,380.00
+14.45%
16,059.00
+3.45%
15,524.00
+8.80%
14,269.00
Accumulated Depreciation
-7,815.00
-15.73%
-6,753.00
-11.14%
-6,076.00
-21.79%
-4,989.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
500.00
+13.90%
439.00
-4.15%
458.00
+0.88%
454.00
Buildings And Improvements
4,570.00
+22.59%
3,728.00
+3.76%
3,593.00
+13.95%
3,153.00
Machinery Furniture Equipment
11,005.00
+11.64%
9,858.00
+6.75%
9,235.00
+15.92%
7,967.00
Construction In Progress
2,305.00
+13.32%
2,034.00
-9.12%
2,238.00
-16.96%
2,695.00
Goodwill And Other Intangible Assets
65,200.00
+6.21%
61,386.00
+1.15%
60,690.00
+3.50%
58,638.00
Goodwill
49,362.00
+7.65%
45,853.00
+4.16%
44,020.00
+6.86%
41,196.00
Other Intangible Assets
15,838.00
+1.96%
15,533.00
-6.82%
16,670.00
-4.43%
17,442.00
Other Non Current Assets
5,871.00
+30.70%
4,492.00
+12.33%
3,999.00
-0.20%
4,007.00
Total Liabilities Net Minority Interest
56,807.00
+19.22%
47,649.00
-8.16%
51,884.00
-2.12%
53,006.00
Current Liabilities
15,189.00
+13.93%
13,332.00
-4.85%
14,012.00
-17.62%
17,010.00
Payables And Accrued Expenses
8,946.00
+8.23%
8,266.00
+7.16%
7,714.00
-12.64%
8,830.00
Payables
3,622.00
+17.64%
3,079.00
+7.21%
2,872.00
-15.05%
3,381.00
Accounts Payable
3,622.00
+17.64%
3,079.00
+7.21%
2,872.00
-15.05%
3,381.00
Current Accrued Expenses
5,324.00
+2.64%
5,187.00
+7.13%
4,842.00
-11.14%
5,449.00
Current Debt And Capital Lease Obligation
3,533.00
+59.58%
2,214.00
-38.65%
3,609.00
-35.31%
5,579.00
Current Debt
3,533.00
+59.58%
2,214.00
-38.65%
3,609.00
-35.31%
5,579.00
Current Deferred Liabilities
2,710.00
-4.98%
2,852.00
+6.06%
2,689.00
+3.38%
2,601.00
Current Deferred Revenue
2,710.00
-4.98%
2,852.00
+6.06%
2,689.00
+3.38%
2,601.00
Total Non Current Liabilities Net Minority Interest
41,618.00
+21.28%
34,317.00
-9.39%
37,872.00
+5.21%
35,996.00
Long Term Debt And Capital Lease Obligation
35,852.00
+23.37%
29,061.00
-7.18%
31,308.00
+8.30%
28,909.00
Long Term Debt
35,852.00
+23.37%
29,061.00
-7.18%
31,308.00
+8.30%
28,909.00
Non Current Deferred Liabilities
1,493.00
+17.74%
1,268.00
-34.03%
1,922.00
-32.54%
2,849.00
Non Current Deferred Taxes Liabilities
1,493.00
+17.74%
1,268.00
-34.03%
1,922.00
-32.54%
2,849.00
Other Non Current Liabilities
4,273.00
+7.15%
3,988.00
-14.09%
4,642.00
+9.53%
4,238.00
Stockholders Equity
53,407.00
+7.71%
49,585.00
+6.10%
46,735.00
+6.27%
43,978.00
Common Stock Equity
53,407.00
+7.71%
49,585.00
+6.10%
46,735.00
+6.27%
43,978.00
Capital Stock
445.00
+0.23%
444.00
+0.45%
442.00
+0.23%
441.00
Common Stock
445.00
+0.23%
444.00
+0.45%
442.00
+0.23%
441.00
Preferred Stock
0.00
0.00
—
—
Share Issued
445.16
+0.30%
443.84
+0.37%
442.19
+0.35%
440.67
Ordinary Shares Number
376.22
-1.20%
380.77
-1.52%
386.65
-0.99%
390.51
Treasury Shares Number
68.94
+9.31%
63.07
+13.55%
55.54
+10.73%
50.16
Additional Paid In Capital
18,563.00
+3.35%
17,962.00
+3.91%
17,286.00
+3.24%
16,743.00
Retained Earnings
59,156.00
+11.40%
53,102.00
+12.11%
47,364.00
+13.01%
41,910.00
Gains Losses Not Affecting Retained Earnings
-2,448.00
+9.23%
-2,697.00
+16.35%
-3,224.00
-4.03%
-3,099.00
Treasury Stock
22,309.00
+16.04%
19,226.00
+27.05%
15,133.00
+25.93%
12,017.00
Minority Interest
129.00
+48.28%
87.00
-18.69%
107.00
-37.06%
170.00
Other Equity Adjustments
-2,448.00
+9.23%
-2,697.00
+16.35%
-3,224.00
-4.03%
-3,099.00
Total Equity Gross Minority Interest
53,536.00
+7.78%
49,672.00
+6.04%
46,842.00
+6.10%
44,148.00
Total Capitalization
89,259.00
+13.49%
78,646.00
+0.77%
78,043.00
+7.07%
72,887.00
Working Capital
13,518.00
+53.53%
8,805.00
-16.75%
10,577.00
+28.69%
8,219.00
Invested Capital
92,792.00
+14.76%
80,860.00
-0.97%
81,652.00
+4.06%
78,466.00
Total Debt
39,385.00
+25.93%
31,275.00
-10.43%
34,917.00
+1.24%
34,488.00
Net Debt
29,533.00
+8.31%
27,266.00
+1.59%
26,840.00
+3.37%
25,964.00
Net Tangible Assets
-11,793.00
+0.07%
-11,801.00
+15.44%
-13,955.00
+4.81%
-14,660.00
Tangible Book Value
-11,793.00
+0.07%
-11,801.00
+15.44%
-13,955.00
+4.81%
-14,660.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
7,818.00
-9.80%
8,667.00
+3.10%
8,406.00
-8.17%
9,154.00
Cash Flow From Continuing Operating Activities
7,819.00
-9.78%
8,667.00
+3.10%
8,406.00
-8.17%
9,154.00
Net Income From Continuing Operations
6,721.00
+6.04%
6,338.00
+6.43%
5,955.00
-14.44%
6,960.00
Depreciation Amortization Depletion
2,780.00
-10.55%
3,108.00
-8.75%
3,406.00
+0.74%
3,381.00
Depreciation
1,050.00
-9.17%
1,156.00
+8.24%
1,068.00
+8.32%
986.00
Amortization Cash Flow
1,730.00
-11.37%
1,952.00
-16.51%
2,338.00
-2.38%
2,395.00
Depreciation And Amortization
2,780.00
-10.55%
3,108.00
-8.75%
3,406.00
+0.74%
3,381.00
Amortization Of Intangibles
1,730.00
-11.37%
1,952.00
-16.51%
2,338.00
-2.38%
2,395.00
Other Non Cash Items
412.00
-11.02%
463.00
-17.62%
562.00
+10.41%
509.00
Stock Based Compensation
310.00
+2.99%
301.00
+8.27%
278.00
-9.45%
307.00
Deferred Tax
-639.00
+47.15%
-1,209.00
+7.00%
-1,300.00
-30.65%
-995.00
Deferred Income Tax
-639.00
+47.15%
-1,209.00
+7.00%
-1,300.00
-30.65%
-995.00
Operating Gains Losses
—
—
—
26.00
Change In Working Capital
-1,766.00
-428.74%
-334.00
+32.53%
-495.00
+50.89%
-1,008.00
Change In Receivables
-426.00
-149.12%
-171.00
-297.67%
-43.00
+90.00%
-430.00
Changes In Account Receivables
-426.00
-149.12%
-171.00
-297.67%
-43.00
+90.00%
-430.00
Change In Inventory
-74.00
-174.07%
-27.00
-104.52%
598.00
+172.48%
-825.00
Change In Payables And Accrued Expense
421.00
+98.58%
212.00
+142.40%
-500.00
-177.16%
648.00
Change In Payable
421.00
+98.58%
212.00
+142.40%
-500.00
-177.16%
648.00
Change In Account Payable
421.00
+98.58%
212.00
+142.40%
-500.00
-177.16%
648.00
Change In Other Working Capital
-1,687.00
-384.77%
-348.00
+36.73%
-550.00
-37.16%
-401.00
Investing Cash Flow
-4,047.00
+30.71%
-5,841.00
-13.59%
-5,142.00
-138.17%
-2,159.00
Cash Flow From Continuing Investing Activities
-4,047.00
+30.71%
-5,841.00
-13.59%
-5,142.00
-138.17%
-2,159.00
Net PPE Purchase And Sale
-1,481.00
-10.28%
-1,343.00
+3.52%
-1,392.00
+37.27%
-2,219.00
Purchase Of PPE
-1,525.00
-8.93%
-1,400.00
+5.34%
-1,479.00
+34.06%
-2,243.00
Sale Of PPE
44.00
-22.81%
57.00
-34.48%
87.00
+262.50%
24.00
Capital Expenditure
-1,525.00
-8.93%
-1,400.00
+5.34%
-1,479.00
+34.06%
-2,243.00
Net Investment Purchase And Sale
1,450.00
+205.53%
-1,374.00
-1017.07%
-123.00
-255.70%
79.00
Purchase Of Investment
-383.00
+88.72%
-3,396.00
-1532.69%
-208.00
-300.00%
-52.00
Sale Of Investment
1,833.00
-9.35%
2,022.00
+2278.82%
85.00
-35.11%
131.00
Net Business Purchase And Sale
-4,037.00
-28.90%
-3,132.00
+14.43%
-3,660.00
-9284.62%
-39.00
Purchase Of Business
-4,037.00
-28.90%
-3,132.00
+14.43%
-3,660.00
-9284.62%
-39.00
Gain Loss On Sale Of Business
—
—
—
—
Net Other Investing Changes
21.00
+162.50%
8.00
-75.76%
33.00
+65.00%
20.00
Financing Cash Flow
1,801.00
+126.52%
-6,792.00
-87.52%
-3,622.00
-28.90%
-2,810.00
Cash Flow From Continuing Financing Activities
1,801.00
+126.52%
-6,791.00
-87.49%
-3,622.00
-28.90%
-2,810.00
Net Issuance Payments Of Debt
5,347.00
+322.51%
-2,403.00
-1450.32%
-155.00
-123.70%
654.00
Issuance Of Debt
8,854.00
+635.38%
1,204.00
-84.08%
7,562.00
+60.25%
4,719.00
Repayment Of Debt
-3,507.00
+2.77%
-3,607.00
+53.26%
-7,717.00
-89.84%
-4,065.00
Long Term Debt Issuance
7,759.00
+544.44%
1,204.00
-79.74%
5,942.00
+86.09%
3,193.00
Long Term Debt Payments
-2,412.00
+33.13%
-3,607.00
+37.62%
-5,782.00
-1441.87%
-375.00
Net Long Term Debt Issuance
5,347.00
+322.51%
-2,403.00
-1601.88%
160.00
-94.32%
2,818.00
Short Term Debt Issuance
1,095.00
0.00
-100.00%
1,620.00
+6.16%
1,526.00
Short Term Debt Payments
-1,095.00
0.00
+100.00%
-1,935.00
+47.56%
-3,690.00
Net Short Term Debt Issuance
0.00
0.00
+100.00%
-315.00
+85.44%
-2,164.00
Net Common Stock Issuance
-3,000.00
+25.00%
-4,000.00
-33.33%
-3,000.00
+0.00%
-3,000.00
Common Stock Payments
-3,000.00
+25.00%
-4,000.00
-33.33%
-3,000.00
+0.00%
-3,000.00
Cash Dividends Paid
-636.00
-9.09%
-583.00
-11.47%
-523.00
-14.95%
-455.00
Repurchase Of Capital Stock
-3,000.00
+25.00%
-4,000.00
-33.33%
-3,000.00
+0.00%
-3,000.00
Proceeds From Stock Option Exercised
—
—
—
—
Net Other Financing Charges
90.00
-53.61%
194.00
+246.43%
56.00
+722.22%
-9.00
Changes In Cash
5,572.00
+240.49%
-3,966.00
-1007.82%
-358.00
-108.55%
4,185.00
Effect Of Exchange Rate Changes
267.00
+393.41%
-91.00
-10.98%
-82.00
+41.01%
-139.00
Beginning Cash Position
4,040.00
-50.10%
8,097.00
-5.15%
8,537.00
+90.09%
4,491.00
End Cash Position
9,879.00
+144.53%
4,040.00
-50.10%
8,097.00
-5.15%
8,537.00
Free Cash Flow
6,293.00
-13.40%
7,267.00
+4.91%
6,927.00
+0.23%
6,911.00
Interest Paid Supplemental Data
1,612.00
+2.68%
1,570.00
+13.36%
1,385.00
+107.65%
667.00
Income Tax Paid Supplemental Data
1,776.00
-3.16%
1,834.00
+23.75%
1,482.00
+20.10%
1,234.00
Sale Of Business
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category